Page last updated: 2024-12-04

inositol 2-monophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

1D-myo-inositol 2-phosphate : A myo-inositol monophosphate in which the phosphate group is located at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

1D-myo-inositol 5-phosphate : An inositol having myo- configuration substituted at position 5 by a phosphate group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160886
CHEBI ID37493
CHEBI ID62383
SCHEMBL ID3472015
SCHEMBL ID399281
SCHEMBL ID7947628
SCHEMBL ID16397863
MeSH IDM0138025

Synonyms (29)

Synonym
C06155
myo-inositol 5-phosphate
1d-myo-inositol 5-phosphate
CHEBI:37493
l-myo-inositol 5-phosphate
myo-inositol 5-(dihydrogen phosphate)
d-myo-inositol 5-phosphate
6EB27547-4501-498A-88C3-7EF88B25EEF1
inositol-2-phosphate, myo-
7336-80-3
[(2r,3s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate
CHEBI:62383 ,
myo-inositol 2-monophosphate
inositol 2-monophosphate
myo-inositol 2-phosphate
1d-myo-inositol 2-(dihydrogen phosphate)
1d-myo-inositol 2-phosphate
inositol 2-phosphate
myo-inositol, 2-(dihydrogen phosphate)
13004-72-3
inositol, 1-(dihydrogen phosphate)
EPITOPE ID:145015
SCHEMBL3472015
SCHEMBL399281
SCHEMBL7947628
SCHEMBL16397863
Q27131826
Q27104410
DTXSID801313434
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (2)

PathwayProteinsCompounds
phytate degradation II06
phytate degradation I316
phytate degradation I021
phytate degradation II011

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (26.32)18.7374
1990's11 (57.89)18.2507
2000's2 (10.53)29.6817
2010's0 (0.00)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]